Preface
Chronic deep brain stimulation (DBS) has been a rapidly evolving area of neurotherapeutics since its initial introduction for the treatment of Parkinson's disease and essential tremor in the 1990s. For these conditions, DBS is now considered accepted therapy for patients failing to adequately respond to medical treatment. Since the 1990s, new clinical indications, anatomic targets, and technologies have contributed to an expanding role for DBS in the treatment of other movement disorders such as dystonia and Tourette syndrome as well as for other neurologic disorders such as epilepsy and cluster headache. Early experience has also been reported for psychiatric syndromes, such as obsessive-compulsive disorder and depression. Experience with DBS in psychiatric disorders is very limited but is reviewed in this volume as neuropsychiatric indications are expected to grow in coming years.
Because of the rapidly increasing application of DBS for neurologic and psychiatric indications and the recruitment of increasing numbers of neurologic, neurosurgical, and psychiatric clinicians to the field, it is appropriate to provide a resource that updates the underlying scientific background, describes methodologies and standards of treatment, and provides information on new technologies essential for clinical success and to advance the field. Deep Brain Stimulation in Neurological and Psychiatric Disorders begins with reviews of the functional anatomy and physiology of motor and nonmotor aspects of the basal ganglia and their connections, which underlie the application of DBS to neurological and psychiatric disorders. This is followed by proposed mechanisms of action of DBS based on functional neuroimaging, molecular, modeling, and neurophysiologic studies in animals and man. Discussions of patient selection, preoperative assessment, operative complications, and brain targeting are followed by chapters concerning microelectrode mapping as well as new and emerging brain imaging alternatives for target localization inside the operating room. DBS for movement disorders, which remains the most common indication, is reviewed in chapters on essential and other tremors, Parkinson's disease, atypical parkinsonism, dystonia, and Tourette syndrome. Postoperative management and treatment outcomes are reviewed in a series of chapters which address immediate and delayed complications, a particularly important chapter on programming. We have also included a discussion of DBS safety with v regard to MRI and other electronic devices, neuropsychological sequelae, and quality of life. Finally, interesting new areas of DBS applications are addressed by experts with experience in epilepsy, obsessive-compulsive disorder, depression, and cluster headache.
We have gathered a group of experienced and recognized authors to review the current state of DBS in neurologic and psychiatric disorders. We thank them for providing a conservative and level-headed approach to the use of DBS with emphasis on objective assessment of clinical outcomes, particularly in the new and emerging applications. We greatly appreciate the efforts of Richard Lansing and Michele Seugling at Humana Press, who have helped to make this work a reality. We also wish to thank our understanding families, without whose love and support this book would not have been possible. Finally, we dedicate this book to our patients and their families, whose continued courage and cooperation in the face of great personal adversity have allowed this work to progress toward providing some measure of relief for their difficult conditions. 
